Literature DB >> 27438123

Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation.

Ben Freedman1, Carlos Martinez2, Anja Katholing2, Stephan Rietbrock2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27438123     DOI： 10.1001/jamacardio.2016.0393

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  17 in total

Review 1.  Management of atrial high-rate episodes detected by cardiac implanted electronic devices.

Authors:  Ben Freedman; Giuseppe Boriani; Taya V Glotzer; Jeff S Healey; Paulus Kirchhof; Tatjana S Potpara
Journal:  Nat Rev Cardiol       Date:  2017-07-06       Impact factor: 32.419

Review 2.  Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.

Authors:  Emelia J Benjamin; Alan S Go; Patrice Desvigne-Nickens; Christopher D Anderson; Barbara Casadei; Lin Y Chen; Harry J G M Crijns; Ben Freedman; Mellanie True Hills; Jeff S Healey; Hooman Kamel; Dong-Yun Kim; Mark S Link; Renato D Lopes; Steven A Lubitz; David D McManus; Peter A Noseworthy; Marco V Perez; Jonathan P Piccini; Renate B Schnabel; Daniel E Singer; Robert G Tieleman; Mintu P Turakhia; Isabelle C Van Gelder; Lawton S Cooper; Sana M Al-Khatib
Journal:  Circulation       Date:  2021-01-25       Impact factor: 29.690

3.  What is next for screening for undiagnosed atrial fibrillation? Artificial intelligence may hold the key.

Authors:  Ramesh Nadarajah; Jianhua Wu; Alejandro F Frangi; David Hogg; Campbell Cowan; Chris P Gale
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-06-06

4.  Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation.

Authors:  David J Seiffge; Gian Marco De Marchis; Masatoshi Koga; Maurizio Paciaroni; Duncan Wilson; Manuel Cappellari; Kosmas Macha Md; Georgios Tsivgoulis; Gareth Ambler; Shoji Arihiro; Leo H Bonati; Bruno Bonetti; Bernd Kallmünzer; Keith W Muir; Paolo Bovi; Henrik Gensicke; Manabu Inoue; Stefan Schwab; Shadi Yaghi; Martin M Brown; Philippe Lyrer; Masahito Takagi; Monica Acciarrese; Hans Rolf Jager; Alexandros A Polymeris; Kazunori Toyoda; Michele Venti; Christopher Traenka; Hiroshi Yamagami; Andrea Alberti; Sohei Yoshimura; Valeria Caso; Stefan T Engelter; David J Werring
Journal:  Ann Neurol       Date:  2020-02-12       Impact factor: 10.422

5.  Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).

Authors:  Miklos Rohla; Thomas W Weiss; Ladislav Pecen; Giuseppe Patti; Jolanta M Siller-Matula; Renate B Schnabel; Richard Schilling; Dipak Kotecha; Markus Lucerna; Kurt Huber; Raffaele De Caterina; Paulus Kirchhof
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

6.  Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study.

Authors:  Finlay A McAlister; Rajibul Mian; Jonas Oldgren; Lars Wallentin; Michael Ezekowitz; Salim Yusuf; Stuart J Connolly; Jeff S Healey
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

7.  Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants.

Authors:  Amélie Gabet; Edouard Chatignoux; Clémence Grave; Alexandre Vallée; Philippe Tuppin; Yannick Béjot; Valérie Olié
Journal:  Clin Epidemiol       Date:  2021-02-19       Impact factor: 4.790

8.  Screening for Atrial Fibrillation in American Indian Adults in a Tribal Primary Care Clinic.

Authors:  Stavros Stavrakis; Khaled Elkholey; Marty M Lofgren; Zain U A Asad; Lancer D Stephens; Ben Freedman
Journal:  J Am Heart Assoc       Date:  2021-04-21       Impact factor: 5.501

9.  Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol.

Authors:  Emma L Veale; Adrian J Stewart; Alistair Mathie; Satvinder K Lall; Melanie Rees-Roberts; Vilius Savickas; Sukvinder K Bhamra; Sarah A Corlett
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

10.  Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.

Authors:  Finlay A McAlister; Natasha Wiebe; Brenda R Hemmelgarn
Journal:  BMJ Open       Date:  2018-01-29       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.